Why is kidney disease hard to spot?
Chronic kidney disease means the kidneys filter the blood less well, for months or years. At first it often causes no symptoms, so many people do not know they have it.
Finding it takes a blood test that measures how well the kidneys filter. In this study, the disease was defined as an estimated filtration rate below 60 mL per minute. Yet this kind of screening is hard to organize in the community and in family practice, even in wealthy countries.
The kidneys and the retina both contain very small blood vessels. The researchers' idea: could a photo of the eye signal a kidney problem?
How did the researchers go about it?
The team used three large studies of the general population in Singapore and China, covering people of different backgrounds. A deep learning AI, which learns by itself from examples, was trained on photos from 5,188 people, then checked on 1,297 others.
It was then tested on two independent groups: 3,735 people in Singapore and 1,538 people in Beijing.
The researchers compared three approaches: the AI reading the photo alone, a model based on simple risk factors (age, sex, ethnicity, diabetes and blood pressure), and a hybrid AI combining both.
What did they find?
Results are given as a score called the area under the curve, where 1 is a perfect result and 0.5 is no better than chance. In the validation group, the photo AI scored 0.911, the risk factor model 0.916 and the hybrid AI 0.938.
In the two test groups, the photo AI scored 0.733 in Singapore and 0.835 in Beijing. In those groups, the risk factor model did as well as it or better.
In people with diabetes or high blood pressure, who are most at risk of kidney disease, the scores stayed close to those of the validation group.
Key figures
- 0.911score of the photo AI in the validation group (1 = perfect, 0.5 = chance)
- 0.733 and 0.835scores of the photo AI in the two test groups, in Singapore and Beijing
- 5,188people whose photos were used to train the AI
Kidneys, eyes and blood tests: keeping track with Mima
This AI is not offered in routine care: to know how your kidneys are doing, the blood test is what counts. But the study shows that diabetes and blood pressure affect both the eyes and the kidneys.
Mima helps you keep track of your eye checks, blood tests and appointments. You can prepare a question for your doctor: "With my diabetes or blood pressure, how often should my kidneys be checked?"
What does this mean for patients?
The authors see retinal photos as an extra, opportunistic tool: someone having an eye check could also get a signal about their kidneys, then be referred for a blood test.
This could help where blood tests are harder to reach. But it is not a test offered in routine care today: in practice, a blood test is still how kidney function is checked.
What are the limits?
The photo AI did less well in the test groups, especially in Singapore (0.733). And a simple model based on age, diabetes or blood pressure did as well or better, so the value of the photo on its own is still unproven.
The study is cross-sectional, meaning it looked at people at a single point in time. It covered Asian populations and did not test the tool in real care.
Frequently asked questions
Can kidney disease be seen in the eye?
This study shows an AI can spot signs of chronic kidney disease on a photo of the retina. It is not a diagnosis: only a blood test measures how well the kidneys work.
What is chronic kidney disease?
It is a lasting drop in the kidneys' ability to filter the blood. It causes few symptoms at first. Diabetes and high blood pressure are common causes.
Does this AI do better than a doctor?
In the study, it did no better than a simple model based on age, diabetes and blood pressure. Its value would be adding a signal during an eye check that is already planned.
Is this test available?
Not in routine care. It is research that has not yet been tested in real care.
The original study
Sabanayagam C, Xu D, Ting DSW, et al. “A deep learning algorithm to detect chronic kidney disease from retinal photographs in community-based populations.” The Lancet Digital Health, May 12, 2020. DOI : 10.1016/S2589-7500(20)30063-7
Read the full study in The Lancet Digital HealthThis article summarizes a scientific study and is not medical advice.